Europe - FRA:2M6 - IE00BTN1Y115 - Common Stock
The current stock price of 2M6.DE is 80.36 EUR. In the past month the price decreased by -0.32%. In the past year, price decreased by -4.23%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 25.46 | 190.51B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 68.18 | 169.63B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 57.72 | 143.61B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 35.98 | 130.10B | ||
| 1MDT.MI | MEDTRONIC PLC | 17.39 | 106.40B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 20.81 | 55.87B | ||
| BOX.DE | BECTON DICKINSON AND CO | 13.01 | 45.89B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 29.69 | 38.70B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.22 | 23.88B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17.3 | 23.99B | ||
| DC4.DE | DEXCOM INC | 41.76 | 24.07B | ||
| QS51.DE | STRAUMANN HOLDING AG-REG | 34.12 | 15.51B |
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
MEDTRONIC PLC
Building Two Parkmore Business Park West
DUBLIN DUBLIN IE
Employees: 95000
Phone: 1135314381700
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
The current stock price of 2M6.DE is 80.36 EUR. The price decreased by -0.45% in the last trading session.
MEDTRONIC PLC (2M6.DE) has a dividend yield of 2.99%. The yearly dividend amount is currently 2.37.
2M6.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for MEDTRONIC PLC (2M6.DE) is 16.85. This is based on the reported non-GAAP earnings per share of 4.77 and the current share price of 80.36 EUR.
The Revenue of MEDTRONIC PLC (2M6.DE) is expected to grow by 7.03% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
MEDTRONIC PLC (2M6.DE) has a market capitalization of 103.08B EUR. This makes 2M6.DE a Large Cap stock.
ChartMill assigns a technical rating of 4 / 10 to 2M6.DE. When comparing the yearly performance of all stocks, 2M6.DE is a bad performer in the overall market: 77.71% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to 2M6.DE. While 2M6.DE has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months 2M6.DE reported a non-GAAP Earnings per Share(EPS) of 4.77. The EPS increased by 5.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.63% | ||
| ROA | 5.12% | ||
| ROE | 9.73% | ||
| Debt/Equity | 0.55 |
39 analysts have analysed 2M6.DE and the average price target is 86.04 EUR. This implies a price increase of 7.07% is expected in the next year compared to the current price of 80.36.
For the next year, analysts expect an EPS growth of 3.35% and a revenue growth 7.03% for 2M6.DE